510(k) Report

510(k) · Cleared

Cleared

Excia Total Hip System

K150062510(k) SpecialCleared Feb 9, 201527-day reviewClass II21 CFR 888.3353

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aesculap Implant Systems, LLC · LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented

Cleared on Feb 9, 2015 as substantially equivalent to K140915 (Aesculap Implant Systems, LLC, 2014) and 1 other predicate after a 27-day review. Its family tree reaches back 10 generations to 1996. 1 later device descends from it.

Decided
Feb 9, 2015
Review
27 days
Class
Class II
Product code
LZO
Recalls
None
Predicates
2

Its longest line of descent runs back 10 generations to K955033 (1996). 80 ancestors in all, the oldest K840643 (1984). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2005: 1 other ancestor2003: 6 other ancestors2004: 1 other ancestor2002: 4 other ancestors2001: 3 other ancestors1992: 1 other ancestor1991: 2 other ancestors2000: 5 other ancestors1999: 2 other ancestors1998: 5 other ancestors1997: 7 other ancestors1996: 6 other ancestors1995: 9 other ancestors1994: 9 other ancestors1990: 2 other ancestors1987: 2 other ancestors1984: 1 other ancestor1993: 1 other ancestor1985: 1 other ancestor2018: 1 descendant clearedK955033 · Rim Flare Acetabular Component · Intermedics Orthopedics · 1996K983509 · Inter-OP Acetabular System - Durasul Acetabular Insert · Sulzer Orthopedics, Inc. · 1999K993259 · Inter-OP Durasul Acetabular Inserts/Cocr Femoral Heads · Sulzer Orthopedics, Inc. · 2000 · recalledK022902 · Smith & Nephew Hip System · Smith & Nephew, Inc. · 2002×2: 2 generations cleared close together, K040191 (2004), K043079 (2004) ×2: 2 generations cleared close together, K060437 (2006), K061344 (2006) K092143 · Excia Total Hip System M an ML Femoral Stem · Aesculap Implant Systems, Inc. · 2009K140915 · Excia Total Hip System · Aesculap Implant Systems, LLC · 201419801990200020102020
  1. Root · 10 generations backK955033 Rim Flare Acetabular ComponentIntermedics Orthopedics · 1996
  2. 6 generations between
  3. 3 generations backK061344 Excia Total Hip System Lateral OffsetAesculap, Inc. · 2006
  4. 2 generations backK092143 Excia Total Hip System M an ML Femoral StemAesculap Implant Systems, Inc. · 2009
  5. 1 generation backK140915 Excia Total Hip SystemAesculap Implant Systems, LLC · 2014
  6. This deviceK150062 Excia Total Hip SystemAesculap Implant Systems, LLC · 2015
  7. Descendant · cites it directly · 0 of its ownK172235 CoreHip® SystemAesculap Implants Systems, LLC · 2018
Show all 10 generations
  1. Root · 10 generations backK955033 Rim Flare Acetabular ComponentIntermedics Orthopedics · 1996
  2. 9 generations backK983509 Inter-OP Acetabular System - Durasul Acetabular InsertSulzer Orthopedics, Inc. · 1999
  3. 8 generations backK993259 Inter-OP Durasul Acetabular Inserts/Cocr Femoral HeadsSulzer Orthopedics, Inc. · 2000 · Recalled
  4. 7 generations backK022902 Smith & Nephew Hip SystemSmith & Nephew, Inc. · 2002
  5. 6 generations backK040191 Bicontact Hip Stem and Femoral HeadAesculap · 2004
  6. 5 generations backK043079 Bicontact Hip System with U-CapAesculap · 2004
  7. 4 generations backK060437 Excia Total Hip System with U-CapAesculap, Inc. · 2006
  8. 3 generations backK061344 Excia Total Hip System Lateral OffsetAesculap, Inc. · 2006
  9. 2 generations backK092143 Excia Total Hip System M an ML Femoral StemAesculap Implant Systems, Inc. · 2009
  10. 1 generation backK140915 Excia Total Hip SystemAesculap Implant Systems, LLC · 2014
  11. This deviceK150062 Excia Total Hip SystemAesculap Implant Systems, LLC · 2015

Most influential descendants

Showing 1 of 1 · See all
  • K172235CoreHip® SystemAesculap Implants Systems, LLC · 2018 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K955033Rim Flare Acetabular ComponentIntermedics Orthopedics1996—
−9K983509Inter-OP Acetabular System - Durasul Acetabular InsertSulzer Orthopedics, Inc.1999—
−8K993259Inter-OP Durasul Acetabular Inserts/Cocr Femoral HeadsSulzer Orthopedics, Inc.20003
−7K022902Smith & Nephew Hip SystemSmith & Nephew, Inc.2002—
−6K040191Bicontact Hip Stem and Femoral HeadAesculap2004—
−5K043079Bicontact Hip System with U-CapAesculap2004—
−4K060437Excia Total Hip System with U-CapAesculap, Inc.2006—
−3K061344Excia Total Hip System Lateral OffsetAesculap, Inc.2006—
−2K092143Excia Total Hip System M an ML Femoral StemAesculap Implant Systems, Inc.2009—
−1K140915Excia Total Hip SystemAesculap Implant Systems, LLC2014—
0 (this device)K150062Excia Total Hip SystemAesculap Implant Systems, LLC2015—
+1K172235CoreHip® SystemAesculap Implants Systems, LLC2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198410
198510
198720
199020
199120
199210
199310
199490
199590
199660
199770
199850
199920
200050
200130
200240
200360
200410
200510
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
FIG. 1 — Lineage of K150062, 1996–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZO device

  1. #1 K192827 Quadra-Pscore 19.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K140915Excia Total Hip System
Summary page 4
…ves that the addition of cemented Excia T femoral stems to Excia Total Hip System is substantially equivalent to Aesculap Implant Systems Excia Total Hip System (510(K)s K140915 and K060918). 4 === P…
Aesculap Implant Systems, LLC2014—
*K060918Excia Total Hip System 12/14 Trunnion with Ceramic Head
Summary page 4
…addition of cemented Excia T femoral stems to Excia Total Hip System is substantially equivalent to Aesculap Implant Systems Excia Total Hip System (510(K)s K140915 and K060918). 4 Sp…
Aesculap, Inc.2006—

Also cleared against K140915: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K172235CoreHip® SystemAesculap Implants Systems, LLC20180

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 7 companies; a new generation was cleared every 1.9 years on median.
  • 21 of the 79 ancestors have a recall of any class.
  • Of its descendants, K172235 (Aesculap Implants Systems, LLC, 2018) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K140915.

How does its category compare?

All LZO devices

LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · LZO

14in 2025

2007: 92008: 112009: 72010: 152011: 132012: 142013: 262014: 132015: 122016: 102017: 162018: 182019: 282020: 182021: 122022: 112023: 102024: 112025: 142026 (partial year): 9
2007high 28 (2019) · low 7 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZO

119in 2025

2007: 87 days median2008: 63 days median2009: 83 days median2010: 78 days median2011: 87 days median2012: 98 days median2013: 100 days median2014: 85 days median2015: 115 days median2016: 177 days median2017: 257 days median2018: 163 days median2019: 109 days median2020: 112 days median2021: 170 days median2022: 279 days median2023: 122 days median2024: 111 days median2025: 119 days median2026 (partial year): 102 days median
2007high 279 (2022) · low 63 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZO

1in 2025

2007: 22008: 132009: 422011: 102012: 142014: 12015: 12016: 92017: 52018: 22019: 42020: 32022: 42023: 22024: 12025: 1
2007high 42 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZO

3,244in 2025

2007: 1382008: 1252009: 1892010: 3942011: 5442012: 9632013: 1,3702014: 1,4772015: 1,3482016: 1,7282017: 2,1652018: 3,1332019: 3,0662020: 1,9632021: 2,1992022: 1,9852023: 2,0662024: 2,5862025: 3,244
2007high 3,244 (2025) · low 125 (2008)2025

MAUDE reports naming product code LZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079872138
2008116313125
200978342189
201015780394
2011138710544
2012149814963
20132610001,370
2014138511,477
20151211511,348
20161017791,728
20171625752,165
20181816323,133
20192810943,066
20201811231,963
20211217002,199
20221127941,985
20231012222,066
20241111112,586
20251411913,244
202691020—

What is it indicated for?

The Excia Hip System is intended to replace a hip joint. The device is intended for: Patients suffering from severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head and nonunion of previous fractures of the femur Patients with congenital hip dysplasia, protrusion acetabuli, or slipped capital femoral ephiphysis Patients suffering from…

Read the full statement (113 words)

The Excia Hip System is intended to replace a hip joint.

The device is intended for:

Patients suffering from severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head and nonunion of previous fractures of the femur

Patients with congenital hip dysplasia, protrusion acetabuli, or slipped capital femoral ephiphysis

Patients suffering from disability due to previous fusion

Patients with acute femoral neck fractures

The Excia Hip System is available with two (2) femoral stems. One is manufactured from CoCr and intended for cemented fixation. The other femoral stem is for uncemented fixation and manufactured from Ti with Plasmapore with or without pCaP®.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K150062: Excia Total Hip System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K150062

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026